Virtus Biotech ETF
11 hedge funds and large institutions have $3.58M invested in Virtus Biotech ETF in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0% more funds holding
Funds holding: 11 → 11 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.96% less ownership
Funds ownership: 25.73% → 24.77% (-0.96%)
20% less capital invested
Capital invested by funds: $4.47M → $3.58M (-$899K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Coldstream Capital Management
Bellevue,
Washington
|
+$316K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$86.2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$40.9K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$12.6K |
| 5 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
+$9.93K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$765K |
| 2 |
FAIM
Financial Advocates Investment Management
Olympia,
Washington
|
-$368K |
| 3 |
PFS
Prospera Financial Services
Dallas,
Texas
|
-$5K |
| 4 |
Morgan Stanley
New York
|
-$3.97K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1.87M | -$765K | -19,265 | -30% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $659K | +$86.2K | +2,170 | +16% |
|
|
3
Citadel Advisors
Miami,
Florida
| $376K | +$12.6K | +316 | +4% |
|
|
CCM
4
Coldstream Capital Management
Bellevue,
Washington
| $328K | +$316K | +7,955 | New |
|
|
MIFH
5
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
| $115K | – | – | – |
|
|
6
Morgan Stanley
New York
| $81K | -$3.97K | -100 | -5% |
|
|
7
UBS Group
Zurich,
Switzerland
| $64K | +$40.9K | +1,029 | +200% |
|
8
Osaic Holdings
Scottsdale,
Arizona
| $49K | – | – | – |
|
|
FWM
9
Focused Wealth Management
Newburgh,
New York
| $17K | – | – | – |
|
|
MCC
10
Money Concepts Capital
Palm Beach Gardens,
Florida
| $10K | – | – | – |
|
|
11
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $10K | +$9.93K | +250 | New |
|
|
FAIM
12
Financial Advocates Investment Management
Olympia,
Washington
| – | -$368K | -8,455 | Closed |
|
|
PFS
13
Prospera Financial Services
Dallas,
Texas
| – | -$5K | -110 | Closed |
|
BBP Hedge Fund Activity: Q2 2022 in Review
11 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q2 2022, worth a combined $3.58M — down 20% from $4.47M a quarter earlier.
Fund positioning in BBP was balanced in Q2 2022: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 2 trimmed.
The largest buyer was Coldstream Capital Management, opening a new position worth an estimated $316K. The largest seller was Royal Bank of Canada, cutting an estimated $765K.
- 11 institutional investors held Virtus Biotech ETF (BBP) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $3.58M of Virtus Biotech ETF stock for Q2 2022, down 20% quarter-over-quarter.
- 2 funds opened new Virtus Biotech ETF positions in Q2 2022 and 2 closed out, a net change of 0 holders.
- The largest Virtus Biotech ETF buyer in Q2 2022 was Coldstream Capital Management, an estimated $316K added.
- The largest Virtus Biotech ETF seller in Q2 2022 was Royal Bank of Canada, an estimated $765K sold.
Based on aggregated 13F filings for Q2 2022.